Cargando…
Complement Inhibition in the Treatment of SLE-Associated Thrombotic Thrombocytopenic Purpura
Autores principales: | Boneparth, Alexis, Moorthy, L. Nandini, Weiss, Lynne, Rajasekhar, Hariprem, Murphy, Susan, Drachtman, Richard A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4784625/ https://www.ncbi.nlm.nih.gov/pubmed/27335943 http://dx.doi.org/10.1177/2333794X15570150 |
Ejemplares similares
-
Thrombotic thrombocytopenic purpura associated with cerebral SLE.
por: McHenry, M., et al.
Publicado: (2003) -
Complement and cytokine response in acute Thrombotic Thrombocytopenic Purpura
por: Westwood, John-Paul, et al.
Publicado: (2014) -
Thrombotic thrombocytopenic purpura
por: Knöbl, Paul
Publicado: (2018) -
Acquired thrombotic thrombocytopenic purpura with isolated CFHR3/1 deletion—rapid remission following complement blockade
por: Bitzan, Martin, et al.
Publicado: (2018) -
Caplacizumab use for immune thrombotic thrombocytopenic purpura: the Milan thrombotic thrombocytopenic purpura registry
por: Agosti, Pasquale, et al.
Publicado: (2023)